<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593494/bin/ActaDV-102-2234-g001.jpg"/> </div> <div class="text-side"> <h1>Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression.</h1> <p>(a, b) Clinical presentation at first visit. (a) Generalized erythroderma and (b) flat nodules on the cheek. (c, d) Histopathological findings of erythrodermic lesion showing superficial dermal band-like infiltration of medium-to large-sized atypical lymphoid cells without epidermotropism (haematoxylin-eosin (H&amp;E), (c) ×40, (d) ×400). (e–g) Immunostaining for (e) CD4, (f) CD8 and (g) CD30 (×100). (h) Histopathological findings of the flat nodule showing nodular infiltration of atypical lymphoid cells in the superficial to deep dermis (H&amp;E ×40).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36000994/" target="_blank">36000994</a></p><p>Type: Premalignant/Malignant, Category: Hematolymphoid</p>
</div> </div></div></body></html>